Picture of Sinovac Biotech logo

SVA Sinovac Biotech Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareMicro Cap

Annual balance sheet for Sinovac Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:20-F20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments1772031,17613,41511,313
Net Total Accounts Receivable
Net Total Receivables77.5114253952609
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets2843501,56014,91512,126
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment70.980.92841,0191,052
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets3704521,90116,74814,115
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities58.287.26802,4131,092
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities1161581,1557,4215,193
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity2532947469,3278,921
Total Liabilities & Shareholders' Equity3704521,90116,74814,115
Total Common Shares Outstanding
Total Preferred Shares Outstanding